Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Baghai

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Fortschritte Der Neurologie-Psychiatrie|December 16, 2011
[Psychotic and non-psychotic denial of pregnancy]M Lieb, I Hummel, S Fürst, et al.
Pharmacology, Biochemistry, and Behavior|July 13, 2006
Neuroactive steroids and affective disordersD Eser, C Schüle, T C Baghai, et al.
Der Nervenarzt|April 28, 2009
[Core symptoms of depression. Effectiveness of antidepressant therapy]J Damm, D Eser, C Schüle, et al.
Neuroscience|March 29, 2011
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?C Schüle, D Eser, T C Baghai, et al.
Journal of Neuroendocrinology|May 26, 2011
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profileC Nothdurfter, G Rammes, T C Baghai, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Tiagabine improves panic and agoraphobia in panic disorder patientsP Zwanzger, T C Baghai, C Schüle, et al.
Pharmacopsychiatry|November 20, 2009
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorderP Zwanzger, D Eser, C Nothdurfter, et al.
Neuropsychobiology|December 18, 2008
Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patientsS Haefner, T C Baghai, C Schule, et al.
Neuroscience Letters|April 20, 2001
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depressionC Minov, T C Baghai, C Schüle, et al.
Neuroreport|July 7, 2000
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatmentP Zill, T C Baghai, P Zwanzger, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Fortschritte Der Neurologie-Psychiatrie|December 16, 2011
[Psychotic and non-psychotic denial of pregnancy]M Lieb, I Hummel, S Fürst, et al.
Pharmacology, Biochemistry, and Behavior|July 13, 2006
Neuroactive steroids and affective disordersD Eser, C Schüle, T C Baghai, et al.
Der Nervenarzt|April 28, 2009
[Core symptoms of depression. Effectiveness of antidepressant therapy]J Damm, D Eser, C Schüle, et al.
Neuroscience|March 29, 2011
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?C Schüle, D Eser, T C Baghai, et al.
Journal of Neuroendocrinology|May 26, 2011
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profileC Nothdurfter, G Rammes, T C Baghai, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Tiagabine improves panic and agoraphobia in panic disorder patientsP Zwanzger, T C Baghai, C Schüle, et al.
Pharmacopsychiatry|November 20, 2009
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorderP Zwanzger, D Eser, C Nothdurfter, et al.
Neuropsychobiology|December 18, 2008
Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patientsS Haefner, T C Baghai, C Schule, et al.
Neuroscience Letters|April 20, 2001
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depressionC Minov, T C Baghai, C Schüle, et al.
Neuroreport|July 7, 2000
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatmentP Zill, T C Baghai, P Zwanzger, et al.
Pageof 4